Clinical Trial Update: Trial of Naproxen Sodium for the Treatment of OCD in Children With PANDAS [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating naproxen sodium for treating OCD symptoms in children with PANDAS has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections
• Obsessive-compulsive Disorder

Drugs mentioned

• Naproxen sodium (naproxen sodium)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: PANDAS, Anxiety Disorder | Phase 4 | Status: TERMINATED